Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial
- 1 February 2015
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 385 (9970) , 775-784
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st centuryInternational Journal of Cardiology, 2013
- The Green, Amber, Red Delineation of Risk and Need (GARDIAN) management system: a pragmatic approach to optimizing heart health from primary prevention to chronic disease managementEuropean Journal of Cardiovascular Nursing, 2012
- Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programAmerican Heart Journal, 2011
- Apixaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2011
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)European Heart Journal, 2010
- Improving the reporting of pragmatic trials: an extension of the CONSORT statementBMJ, 2008
- Prolonged Effects of a Home-Based Intervention in Patients With Chronic IllnessArchives of internal medicine (1960), 2006
- A Comparison of Rate Control and Rhythm Control in Patients with Atrial FibrillationNew England Journal of Medicine, 2002
- EQ-SD: a measure of health status from the EuroQol GroupAnnals of Medicine, 2001
- The CES-D ScaleApplied Psychological Measurement, 1977